Interaction of mouse intestinal P-glycoprotein with oral antidiabetic drugs and its inhibitors.
Kalsi, Harman; Grewal, Ravneet K.
Indian J Exp Biol
; 2015 Sept; 53(9): 611-616
Artículo en Inglés | IMSEAR | ID: sea-178556
Documentos relacionados
Interaction of mouse intestinal P-glycoprotein with oral antidiabetic drugs and its inhibitors.
In Vitro Modulation of Glibenclamide Transport by P-glycoprotein Inhibitory Antidiabetic African Plant Extracts.
Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules.
Approaches to minimize the effects of P-glycoprotein in drug transport: A review.
Characterization of P-glycoprotein orthologs from human, sheep, pig, dog, and cat.
In Vitro Evaluation of the Interaction of Seven Biologically Active Components in <i>Anemarrhenae rhizoma</i> with P-gp.
Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery-A Concise Outlook.
Study Models of Drug-Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels.
Spectroscopic interactions of non-insulin-dependent diabetes mellitus with levocetirizine.
Effects of hypoxia on the expression and function of P-gp in Caco-2 cells.